Genomic and Epigenomic Integration Identifies a Prognostic Signature in Colon Cancer

Abstract

CRC that have silenced genes in ECM pathway components show worse survival suggesting that our finding provides novel prognostic biomarkers for CRC and reflects the high importance of integrative analyses linking genetic and epigenetic abnormalities with pathway disruption in cancer.